The DOI matches its Crossref record; 438 of the 438 references it cites were found in a registry or an index.
α-Synuclein misfolding and Parkinson's disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 438
Giehm, L., Svergun, D. I., Otzen, D. E., & Vestergaard, B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013225108 · Cited by 241
Environmental Factors in Parkinson’s Disease
Di Monte, D. A., Lavasani, M., & Manning-Bog, A. B. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00099-2 · Cited by 240
Junn, E., Ronchetti, R. D., Quezado, M. M., Kim, S.-Y., & Mouradian, M. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438021100 · Cited by 238
Münch, G., Lüth, H. J., Wong, A., Arendt, T., Hirsch, E., Ravid, R., & Riederer, P. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00096-x · Cited by 231
Multiple Independent Binding Sites for Small-Molecule Inhibitors on the Oncoprotein c-Myc
Hammoudeh, D. I., Follis, A. V., Prochownik, E. V., & Metallo, S. J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja900616b · Cited by 229
Fredenburg, R. A., Rospigliosi, C., Meray, R. K., Kessler, J. C., Lashuel, H. A., Eliezer, D., & Lansbury, P. T. (2007) · Biochemistry · doi:10.1021/bi7000246 · Cited by 227
Single Particle Characterization of Iron-induced Pore-forming α-Synuclein Oligomers
Kostka, M., Högen, T., Danzer, K. M., Levin, J., Habeck, M., Wirth, A., Wagner, R., Glabe, C. G., Finger, S., Heinzelmann, U., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709634200 · Cited by 226
Rekas, A., Adda, C. G., Andrew Aquilina, J., Barnham, K. J., Sunde, M., Galatis, D., Williamson, N. A., Masters, C. L., Anders, R. F., Robinson, C. V., et al. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.05.054 · Cited by 223
Rochet, J.-C., Conway, K. A., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi001315u · Cited by 222
Methionine oxidation inhibits fibrillation of human α‐synuclein in vitro
Uversky, V. N., Yamin, G., Souillac, P. O., Goers, J., Glaser, C. B., & Fink, A. L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02638-8 · Cited by 222
Self-citationAccelerated Oligomerization by Parkinson's Disease Linked α‐Synuclein Mutants
CONWAY, K. A., LEE, S. ‐., ROCHET, J. ‐., DING, T. T., HARPER, J. D., WILLIAMSON, R. E., & LANSBURY, P. T. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06903.x · Cited by 222
An amyloid-forming segment of β2-microglobulin suggests a molecular model for the fibril
Ivanova, M. I., Sawaya, M. R., Gingery, M., Attinger, A., & Eisenberg, D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403756101 · Cited by 219
Rifampicin Inhibits α-Synuclein Fibrillation and Disaggregates Fibrils
Li, J., Zhu, M., Rajamani, S., Uversky, V. N., & Fink, A. L. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.08.025 · Cited by 218
Self-citationChen, L., Periquet, M., Wang, X., Negro, A., McLean, P. J., Hyman, B. T., & Feany, M. B. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39088 · Cited by 215
Role of Protein−Water Interactions and Electrostatics in α-Synuclein Fibril Formation
Munishkina, L. A., Henriques, J., Uversky, V. N., & Fink, A. L. (2004) · Biochemistry · doi:10.1021/bi034938r · Cited by 215
Self-citationMagnesium Inhibits Spontaneous and Iron-induced Aggregation of α-Synuclein
Golts, N., Snyder, H., Frasier, M., Theisler, C., Choi, P., & Wolozin, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107866200 · Cited by 214
da Costa, C. A., Ancolio, K., & Checler, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002413200 · Cited by 213
Methylene Blue Inhibits Amyloid Aβ Oligomerization by Promoting Fibrillization
Necula, M., Breydo, L., Milton, S., Kayed, R., van der Veer, W. E., Tone, P., & Glabe, C. G. (2007) · Biochemistry · doi:10.1021/bi700411k · Cited by 213
Self-citationRapid Anionic Micelle-mediated α-Synuclein Fibrillization in Vitro
Necula, M., Chirita, C. N., & Kuret, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308231200 · Cited by 211
Beyer, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0104-6 · Cited by 209
Conformational Equilibria in Monomeric α-Synuclein at the Single-Molecule Level
Sandal, M., Valle, F., Tessari, I., Mammi, S., Bergantino, E., Musiani, F., Brucale, M., Bubacco, L., & Samorì, B. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060006 · Cited by 204
Yoshimoto, M., Iwai, A., Kang, D., Otero, D. A., Xia, Y., & Saitoh, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9141 · Cited by 203
Tubulin Seeds α-Synuclein Fibril Formation
Alim, M. A., Hossain, M. S., Arima, K., Takeda, K., Izumiyama, Y., Nakamura, M., Kaji, H., Shinoda, T., Hisanaga, S., & Uéda, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m102981200 · Cited by 200
Allison, J. R., Varnai, P., Dobson, C. M., & Vendruscolo, M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja904716h · Cited by 200
Uversky, V. N., Li, J., Bower, K., & Fink, A. L. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00067-0 · Cited by 200
Self-citationKuwahara, T., Koyama, A., Gengyo-Ando, K., Masuda, M., Kowa, H., Tsunoda, M., Mitani, S., & Iwatsubo, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m504860200 · Cited by 200
Induction of Neuronal Cell Death by Rab5A-dependent Endocytosis of α-Synuclein
Sung, J. Y., Kim, J., Paik, S. R., Park, J. H., Ahn, Y. S., & Chung, K. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101318200 · Cited by 200
α-Synuclein Misfolding and Neurodegenerative Diseases
Uversky, V. (2008) · Current Protein & Peptide Science · doi:10.2174/138920308785915218 · Cited by 198
Self-citationCurcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model
Wang, M. S., Boddapati, S., Emadi, S., & Sierks, M. R. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-57 · Cited by 197
The role of α-synuclein in neurodegenerative diseases
Bennett, M. C. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.010 · Cited by 197
Guiding Protein Aggregation with Macromolecular Crowding
Munishkina, L. A., Ahmad, A., Fink, A. L., & Uversky, V. N. (2008) · Biochemistry · doi:10.1021/bi8008399 · Cited by 196
Self-citationLindersson, E., Lundvig, D., Petersen, C., Madsen, P., Nyengaard, J. R., Højrup, P., Moos, T., Otzen, D., Gai, W.-P., Blumbergs, P. C., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410409200 · Cited by 196
Waxman, E. A., & Giasson, B. I. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0297-11.2011 · Cited by 194
Molecular Cross Talk between Misfolded Proteins in Animal Models of Alzheimer's and Prion Diseases
Morales, R., Estrada, L. D., Diaz-Espinoza, R., Morales-Scheihing, D., Jara, M. C., Castilla, J., & Soto, C. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5924-09.2010 · Cited by 194
Abedini, A., & Raleigh, D. P. (2009) · Protein Engineering Design and Selection · doi:10.1093/protein/gzp036 · Cited by 192
Effect of 4-Hydroxy-2-nonenal Modification on α-Synuclein Aggregation
Qin, Z., Hu, D., Han, S., Reaney, S. H., Di Monte, D. A., & Fink, A. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608126200 · Cited by 191
Azeredo da Silveira, S., Schneider, B. L., Cifuentes-Diaz, C., Sage, D., Abbas-Terki, T., Iwatsubo, T., Unser, M., & Aebischer, P. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn417 · Cited by 190
Lo Bianco, C., Shorter, J., Régulier, E., Lashuel, H., Iwatsubo, T., Lindquist, S., & Aebischer, P. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35781 · Cited by 190
Improved low molecular weight Myc-Max inhibitors
Wang, H., Hammoudeh, D. I., Follis, A. V., Reese, B. E., Lazo, J. S., Metallo, S. J., & Prochownik, E. V. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0005 · Cited by 190
Ladiwala, A. R. A., Dordick, J. S., & Tessier, P. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.173856 · Cited by 188
Familial Mutants of α-Synuclein with Increased Neurotoxicity Have a Destabilized Conformation
Bertoncini, C. W., Fernandez, C. O., Griesinger, C., Jovin, T. M., & Zweckstetter, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500288200 · Cited by 187
Structure and Properties of a Complex of α-Synuclein and a Single-Domain Camelid Antibody
De Genst, E. J., Guilliams, T., Wellens, J., O'Day, E. M., Waudby, C. A., Meehan, S., Dumoulin, M., Hsu, S.-T. D., Cremades, N., Verschueren, K. H. G., et al. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.07.001 · Cited by 186
The Oxidative Stress Metabolite 4-Hydroxynonenal Promotes Alzheimer Protofibril Formation
Siegel, S. J., Bieschke, J., Powers, E. T., & Kelly, J. W. (2007) · Biochemistry · doi:10.1021/bi061853s · Cited by 185
Small heat shock proteins protect against α-synuclein-induced toxicity and aggregation
Outeiro, T. F., Klucken, J., Strathearn, K. E., Liu, F., Nguyen, P., Rochet, J.-C., Hyman, B. T., & McLean, P. J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.085 · Cited by 185
Environmental Factors in the Etiology of Parkinson's Disease
Tanner, C. M., Chen, B., Wang, W.-Z., Peng, M.-L., Liu, Z.-L., Liang, X.-L., Kao, L. C., Gilley, D. W., & Schoenberg, B. S. (1987) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100037835 · Cited by 184
Enhanced Phosphatase Activity Attenuates α-Synucleinopathy in a Mouse Model
Lee, K.-W., Chen, W., Junn, E., Im, J.-Y., Grosso, H., Sonsalla, P. K., Feng, X., Ray, N., Fernandez, J. R., Chao, Y., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6513-10.2011 · Cited by 184
Protein aggregate spreading in neurodegenerative diseases: Problems and perspectives
Lee, S.-J., Lim, H.-S., Masliah, E., & Lee, H.-J. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.05.008 · Cited by 184
Solvent-induced collapse of α-synuclein and acid-denatured cytochrome c
Pielak, G. J., Morar, A. S., Olteanu, A., & Young, G. B. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/wshb-5d82 · Cited by 184
Stefani, M. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07889.x · Cited by 183
Alpha-Synuclein Is a Cellular Ferrireductase
Davies, P., Moualla, D., & Brown, D. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015814 · Cited by 183
Lucchini, R. G., Martin, C. J., & Doney, B. C. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8108-8 · Cited by 182
Norris, E. H., Giasson, B. I., Ischiropoulos, H., & Lee, V. M.-Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212436200 · Cited by 181
A role for helical intermediates in amyloid formation by natively unfolded polypeptides?
Abedini, A., & Raleigh, D. P. (2009) · Physical Biology · doi:10.1088/1478-3975/6/1/015005 · Cited by 179
Identification of Novel Proteins Associated with Both α-Synuclein and DJ-1
Jin, J., Li, G. J., Davis, J., Zhu, D., Wang, Y., Pan, C., & Zhang, J. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600182-mcp200 · Cited by 179
Putcha, P., Danzer, K. M., Kranich, L. R., Scott, A., Silinski, M., Mabbett, S., Hicks, C. D., Veal, J. M., Steed, P. M., Hyman, B. T., et al. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.158436 · Cited by 179
Certain Metals Trigger Fibrillation of Methionine-oxidized α-Synuclein
Yamin, G., Glaser, C. B., Uversky, V. N., & Fink, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303302200 · Cited by 178
Self-citationStructural Characteristics of α-Synuclein Oligomers Stabilized by the Flavonoid Baicalein
Hong, D.-P., Fink, A. L., & Uversky, V. N. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.08.039 · Cited by 177
Self-citationCa2+ Binding to α-Synuclein Regulates Ligand Binding and Oligomerization
Nielsen, M. S., Vorum, H., Lindersson, E., & Jensen, P. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101181200 · Cited by 176
CHIP Targets Toxic α-Synuclein Oligomers for Degradation
Tetzlaff, J. E., Putcha, P., Outeiro, T. F., Ivanov, A., Berezovska, O., Hyman, B. T., & McLean, P. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802283200 · Cited by 175
Lu, J., Ardah, M. T., Durairajan, S. S. K., Liu, L., Xie, L., Fong, W. D., Hasan, M. Y., Huang, J., El‐Agnaf, O. M. A., & Li, M. (2011) · ChemBioChem · doi:10.1002/cbic.201000604 · Cited by 174
Rott, R., Szargel, R., Haskin, J., Shani, V., Shainskaya, A., Manov, I., Liani, E., Avraham, E., & Engelender, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704809200 · Cited by 174
Aluminum-containing antacids as a cause of idiopathic Parkinson's disease
Altschuler, E. (1999) · Medical Hypotheses · doi:10.1054/mehy.1997.0701 · Cited by 173
Binolfi, A., Lamberto, G. R., Duran, R., Quintanar, L., Bertoncini, C. W., Souza, J. M., Cerveñansky, C., Zweckstetter, M., Griesinger, C., & Fernández, C. O. (2008) · Journal of the American Chemical Society · doi:10.1021/ja803494v · Cited by 172
Environmental factors and Parkinson's disease: A case‐control study in China
Tanner, C. M., Chen, B., Wang, W., Peng, M., Liu, Z., Liang, X., Kao, L. C., Gilley, D. W., Goetz, C. G., & Schoenberg, B. S. (1989) · Neurology · doi:10.1212/wnl.39.5.660 · Cited by 170
Methionine oxidation, α-synuclein and Parkinson's disease
Glaser, C. B., Yamin, G., Uversky, V. N., & Fink, A. L. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.10.008 · Cited by 168
Self-citationPrion hypothesis: the end of the controversy?
Soto, C. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.11.001 · Cited by 168
Nitration inhibits fibrillation of human α‐synuclein in vitro by formation of soluble oligomers
Yamin, G., Uversky, V. N., & Fink, A. L. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00367-3 · Cited by 167
Self-citationLowe, R., Pountney, D. L., Jensen, P. H., Gai, W. P., & Voelcker, N. H. (2004) · Protein Science · doi:10.1110/ps.04879704 · Cited by 165
Calcium, magnesium and aluminum concentrations in Parkinson's disease.
YASUI, M., Kihira, T., & Ota, K. (1992) · PubMed · Cited by 163
Parkinson's disease mortality and the industrial use of heavy metals in Michigan
Rybicki, B. A., Johnson, C. C., Uman, J., & Gorell, J. M. (1993) · Movement Disorders · doi:10.1002/mds.870080116 · Cited by 163
Structural characterization of the molten globule of α‐lactalbumin by solution X‐ray scattering
Kataoka, M., Tokunaga, F., Kuwajima, K., & Goto, Y. (1997) · Protein Science · doi:10.1002/pro.5560060219 · Cited by 161
Jensen, P. H., Højrup, P., Hager, H., Nielsen, M. S., JACOBSEN, L., Olesen, O. F., Gliemann, J., & Jakes, R. (1997) · Biochemical Journal · doi:10.1042/bj3230539 · Cited by 160
Oncogenic Partnerships: EWS-FLI1 Protein Interactions Initiate Key Pathways of Ewing's Sarcoma
Erkizan, H. V., Uversky, V. N., & Toretsky, J. A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2261 · Cited by 160
Self-citationAnti-HIV Activity of Medicinal Herbs: Usage and Potential Development
Wu, J. A., Attele, A. S., Zhang, L., & Yuan, C.-S. (2001) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x01000083 · Cited by 158
Self-citationLi, J., Uversky, V. N., & Fink, A. L. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00066-9 · Cited by 158
Self-citationOestreicher, E., Sengstock, G. J., Riederer, P., Olanow, C. W., Dunn, A. J., & Arendash, G. W. (1994) · Brain Research · doi:10.1016/0006-8993(94)90833-8 · Cited by 156
Raised calcium promotes α-synuclein aggregate formation
Nath, S., Goodwin, J., Engelborghs, Y., & Pountney, D. L. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.12.004 · Cited by 154
Natively Unfolded Human Prothymosin α Adopts Partially Folded Collapsed Conformation at Acidic pH
Uversky, V. N., Gillespie, J. R., Millett, I. S., Khodyakova, A. V., Vasiliev, A. M., Chernovskaya, T. V., Vasilenko, R. N., Kozlovskaya, G. D., Dolgikh, D. A., Fink, A. L., et al. (1999) · Biochemistry · doi:10.1021/bi990752+ · Cited by 154
Self-citationRao, J. N., Jao, C. C., Hegde, B. G., Langen, R., & Ulmer, T. S. (2010) · Journal of the American Chemical Society · doi:10.1021/ja100646t · Cited by 151
Occupational Metal Exposures and the Risk of Parkinson’s Disease
Gorell, J. M., Rybicki, B. A., Johnson, C. C., & Peterson, E. L. (1999) · Neuroepidemiology · doi:10.1159/000026225 · Cited by 150
Parkinson's Disease and Related α‐Synucleinopathies Are Brain Amyloidoses
Trojanowski, J. Q., & LEE, V. M. ‐. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07468.x · Cited by 150
Paik, S. R., Lee, J., Kim, D.-H., Chang, C., & Kim, J. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0207 · Cited by 149
Inden, M., Kitamura, Y., Abe, M., Tamaki, A., Takata, K., & Taniguchi, T. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.92 · Cited by 149
Eriksen, J., Jørgensen, T. N., & Gether, U. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06599.x · Cited by 148
Unique copper‐induced oligomers mediate alpha‐synuclein toxicity
Wright, J. A., Wang, X., & Brown, D. R. (2009) · The FASEB Journal · doi:10.1096/fj.09-130039 · Cited by 147
Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers
Lee, H.-J., Baek, S. M., Ho, D. H., Suk, J., Cho, E.-D., & Lee, S. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.4.026 · Cited by 140
α-Synuclein Affects the MAPK Pathway and Accelerates Cell Death
Iwata, A., Maruyama, M., Kanazawa, I., & Nukina, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103736200 · Cited by 140
Ahn, B., Rhim, H., Kim, S. Y., Sung, Y., Lee, M., Choi, J., Wolozin, B. L., Chang, J., Lee, Y. H., Kwon, T. K., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110414200 · Cited by 140
Sampathu, D. M., Giasson, B. I., Pawlyk, A. C., Trojanowski, J. Q., & Lee, V. M. ‐. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63633-4 · Cited by 139
Membrane Permeabilization by Oligomeric α-Synuclein: In Search of the Mechanism
van Rooijen, B. D., Claessens, M. M. A. E., & Subramaniam, V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014292 · Cited by 139
Residual Structure, Backbone Dynamics, and Interactions within the Synuclein Family
Sung, Y., & Eliezer, D. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.07.008 · Cited by 137
Interactions between Hsp70 and the Hydrophobic Core of α-Synuclein Inhibit Fibril Assembly
Luk, K. C., Mills, I. P., Trojanowski, J. Q., & Lee, V. M. ‐. (2008) · Biochemistry · doi:10.1021/bi801475r · Cited by 137
Nonaka, T., Iwatsubo, T., & Hasegawa, M. (2004) · Biochemistry · doi:10.1021/bi0485528 · Cited by 137
The role of transition metals in the pathogenesis of Parkinson's disease
Kienzl, E., Puchinger, L., Jellinger, K. A., Linert, W., Stachelberger, H., & Jameson, R. F. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00210-s · Cited by 136
Sevcsik, E., Trexler, A., Dunn, J. M., & Rhoades, E. R. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2009554 · Cited by 136
Association between cardiac denervation and parkinsonism caused by α‐synuclein gene triplication
Singleton, A., Gwinn, K. A., Sharabi, Y., Li, S., Holmes, C. S., Dendi, R., Hardy, J., Singleton, A., Crawley, A., & Goldstein, D. S. (2004) · Brain · doi:10.1093/brain/awh081 · Cited by 136
Uitti, R. J., Rajput, A. H., Rozdilsky, B., Bickis, M., Wollin, T., & Yuen, W. K. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029140 · Cited by 135
Jensen, P. H., Islam, K., Kenney, J. M., Nielsen, M. S., Power, J., & Gai, W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000099200 · Cited by 134
parkin counteracts symptoms in a Drosophila model of Parkinson's disease
Haywood, A. F. M., & Staveley, B. E. (2004) · BMC Neuroscience · doi:10.1186/1471-2202-5-14 · Cited by 133
Näsström, T., Fagerqvist, T., Barbu, M., Karlsson, M., Nikolajeff, F. K., Kasrayan, A., Ekberg, M., Lannfelt, L., Ingelsson, M., & Bergström, J. J. E. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.027 · Cited by 132
Common Crowding Agents Have Only a Small Effect on Protein-Protein Interactions
Phillip, Y., Sherman, E., Haran, G., & Schreiber, G. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.05.026 · Cited by 132
Effects of Various Flavonoids on the α -Synuclein Fibrillation Process
Meng, X., Munishkina, L. A., Fink, A. L., & Uversky, V. N. (2010) · Parkinson s Disease · doi:10.4061/2010/650794 · Cited by 131
Self-citationDanielson, S. R., Held, J. M., Schilling, B., Oo, M. L., Gibson, B. W., & Andersen, J. K. (2009) · Analytical Chemistry · doi:10.1021/ac901176t · Cited by 130
Hejjaoui, M., Haj‐Yahya, M., Kumar, K. S. A., Brik, A., & Lashuel, H. A. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201005546 · Cited by 130
Alpha‐synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells
Tehranian, R., Montoya, S. E., Laar, A. D. V., Hastings, T. G., & Perez, R. G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04146.x · Cited by 128
Structural changes in α‐synuclein affect its chaperone‐like activity in vitro
Kim, T. D., Paik, S. R., Yang, C., & Kim, J. (2000) · Protein Science · doi:10.1110/ps.9.12.2489 · Cited by 127
The human NACP/α-synuclein gene: chromosome assignment to 4q21.3–q22 and TaqI RFLP analysis
Chen, X., de Silva, H. A. R., Pettenati, M. J., Rao, P. N., George‐Hyslop, P. S., Roses, A. D., Xia, Y., Horsburgh, K. J., Uéda, K., & Saitoh, T. (1995) · Genomics · doi:10.1016/0888-7543(95)80237-g · Cited by 125
Occupational Metal Exposures and the Risk of Parkinson’s Disease
Raterman, K. (2011) · Cited by 124
Facteurs environnementaux dans l'étiologie de la maladie de Parkinson
Zayed, J., Ducic, S., Campanella, G., Panisset, J.-C., André, P., Masson, H., & Roy, M. (1990) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100030584 · Cited by 124
Binding of α-Synuclein Affects the Lipid Packing in Bilayers of Small Vesicles
Kamp, F., & Beyer, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512292200 · Cited by 123
Tissue transglutaminase catalyzes the formation of alpha‐synuclein crosslinks in Parkinson's disease
Andringa, G., Lam, K., Chegary, M., Wang, X., Chase, T. N., & Bennett, M. C. (2004) · The FASEB Journal · doi:10.1096/fj.03-0829fje · Cited by 123
Wu, K., Kim, S., Fela, D. A., & Baum, J. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.03.017 · Cited by 122
Dudzik, C. G., Walter, É., & Millhauser, G. L. (2011) · Biochemistry · doi:10.1021/bi101912q · Cited by 122
Ikezoe, T., Chen, S. S., Heber, D., Taguchi, H., & Koeffler, H. P. (2001) · The Prostate · doi:10.1002/pros.10024 · Cited by 120
Ribeiro, C. S., Carneiro, K., Ross, C. A., Menezes, J. R. L., & Engelender, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201115200 · Cited by 119
Uversky, V. N., Karnoup, A. S., Segel, D. J., Seshadri, S., Doniach, S., & Fink, A. L. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1741 · Cited by 119
Self-citationHerrera, F. E., Chesi, A., Paleologou, K. E., Schmid, A. W., Munoz, A., Vendruscolo, M., Gustincich, S., Lashuel, H. A., & Carloni, P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003394 · Cited by 119
Nishie, M., Mori, F., Fujiwara, H., Hasegawa, M., Yoshimoto, M., Iwatsubo, T., Takahashi, H., & Wakabayashi, K. (2004) · Acta Neuropathologica · doi:10.1007/s00401-003-0811-1 · Cited by 118
Huntington, J. A., Pannu, N. S., Hazes, B., Read, R. J., Lomas, D. A., & Carrell, R. W. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3184 · Cited by 118
Arrangement of subunits and ordering of β-strands in an amyloid sheet
Serag, A. A., Altenbach, C., Gingery, M., Hubbell, W. L., & Yeates, T. O. (2002) · Nature Structural Biology · doi:10.1038/nsb838 · Cited by 117
Ulusoy, A., Febbraro, F., Jensen, P. H., Kirik, D., & Romero‐Ramos, M. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07284.x · Cited by 115
Copper- and iron-induced differential fibril formation in α-synuclein: TEM study
..., B., Indi, S. S., & Rao, K. S. J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.06.052 · Cited by 115
Crowded Cell-like Environment Accelerates the Nucleation Step of Amyloidogenic Protein Misfolding
Zhou, Z., Fan, J.-B., Zhu, H., Shewmaker, F. P., Yan, X., Chen, X., Chen, J., Xiao, G., Guo, L., & Liang, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.002832 · Cited by 114
Modulation of α-Synuclein Aggregation by Dopamine: A Review
Leong, S. L., Cappai, R., Barnham, K. J., & Pham, C. L. L. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9986-8 · Cited by 111
NMR mapping of copper binding sites in alpha-synuclein
Sung, Y., Rospigliosi, C. C., & Eliezer, D. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.11.003 · Cited by 111
Smoking and Parkinson's disease: Does nicotine affect α-synuclein fibrillation?
Hong, D.-P., Fink, A. L., & Uversky, V. N. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.09.026 · Cited by 109
Self-citationNitrated α-Synuclein Induces the Loss of Dopaminergic Neurons in the Substantia Nigra of Rats
Yu, Z., Xu, X., Xiang, Z., Zhou, J., Zhang, Z., Hu, C., & He, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009956 · Cited by 109
Phosphorylation, lipid raft interaction and traffic of α-synuclein in a yeast model for Parkinson
Zabrocki, P., Bastiaens, I., Delay, C., Bammens, T., Ghillebert, R., Pellens, K., VIRGILIO, C. D., LEUVEN, F. V., & Winderickx, J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.06.010 · Cited by 109
Chen, L., Yan, W., Wang, X., & He, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009052 · Cited by 108
TorsinA accumulation in Lewy bodies in sporadic Parkinson’s disease
Shashidharan, P., Good, P. F., Hsu, A., Perl, D. P., Brin, M. F., & Olanow, C. W. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02702-5 · Cited by 107
Membrane-mediated Amyloidogenesis and the Promotion of Oxidative Lipid Damage by Amyloid β Proteins
Murray, I. V. J., Liu, L., Komatsu, H., Uryu, K., Xiao, G., Lawson, J. A., & Axelsen, P. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608589200 · Cited by 106
α‐Synuclein modulation of Ca2+signaling in human neuroblastoma (SH‐SY5Y) cells
Hettiarachchi, N. T., Parker, A., Dallas, M. L., Pennington, K., Hung, C., Pearson, H. A., Boyle, J. P., Robinson, P. A., & Peers, C. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06411.x · Cited by 106
Cu2+Binding Modes of Recombinant α-Synuclein − Insights from EPR Spectroscopy
Drew, S. C., Leong, S. L., Pham, C. L. L., Tew, D. J., Masters, C. L., Miles, L. A., Cappai, R., & Barnham, K. J. (2008) · Journal of the American Chemical Society · doi:10.1021/ja800708x · Cited by 106
Shaikh, S. B., & Nicholson, L. F. B. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21644 · Cited by 106
Mutant and Wild-Type α-Synuclein Interact with Mitochondrial Cytochrome C Oxidase
Elkon, H., Don, J., Melamed, E., Ziv, I., Shirvan, A., & Offen, D. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:18:3:229 · Cited by 106
Dietary intake of metals and risk of Parkinson's disease: A case-control study in Japan
Miyake, Y., Tanaka, K., Fukushima, W., Sasaki, S., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., Miki, T., Kawamura, N., et al. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.03.035 · Cited by 106
Immunohistochemical localization and distribution of torsinA in normal human and rat brain
Shashidharan, P., Kramer, B. C., Walker, R. H., Olanow, C. W., & Brin, M. F. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02232-5 · Cited by 105
Small Molecule Oxidation Products Trigger Disease-Associated Protein Misfolding
Bieschke, J., Zhang, Q., Bosco, D. A., Lerner, R. A., Powers, E. T., Wentworth, P., & Kelly, J. W. (2006) · Accounts of Chemical Research · doi:10.1021/ar0500766 · Cited by 105
Ng, K. P., Potikyan, G., Savene, R. O. V., Denny, C. T., Uversky, V. N., & Lee, K. A. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607007104 · Cited by 104
Self-citationMetalloproteomics and metal toxicology of α-synuclein
Santner, A. A., & Uversky, V. N. (2010) · Metallomics · doi:10.1039/b926659c · Cited by 104
Self-citationα-Synuclein Populates Both Elongated and Broken Helix States on Small Unilamellar Vesicles
Lokappa, S. B., & Ulmer, T. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.224055 · Cited by 103
Heavy metals and the etiology of Parkinson's disease and other movement disorders
Montgomery, E. B. (1995) · Toxicology · doi:10.1016/0300-483x(94)02962-t · Cited by 103
E46K Parkinson’s-Linked Mutation Enhances C-Terminal-to-N-Terminal Contacts in α-Synuclein
Rospigliosi, C. C., McClendon, S., Schmid, A. W., Ramlall, T. F., Barré, P., Lashuel, H. A., & Eliezer, D. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.03.065 · Cited by 102
alpha-Synuclein forms a complex with transcription factor Elk-1
Iwata, A., Miura, S., Kanazawa, I., Sawada, M., & Nukina, N. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.t01-1-00232.x · Cited by 101
Parkinson's Disease-associated α-Synuclein Is a Calmodulin Substrate
Martinez, J., Moeller, I., Erdjument‐Bromage, H., Tempst, P., & Lauring, B. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209020200 · Cited by 100
Zhou, W., Long, C., Reaney, S. H., Monte, D. A. D., Fink, A. L., & Uversky, V. N. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.004 · Cited by 99
Self-citationRole of Individual Methionines in the Fibrillation of Methionine-Oxidized α-Synuclein
Hokenson, M. J., Uversky, V. N., Goers, J. W. F., Yamin, G., Munishkina, L. A., & Fink, A. L. (2004) · Biochemistry · doi:10.1021/bi049979h · Cited by 97
Self-citationParkinsons Disease and other α-Synucleinopathies
Goedert, M. (2001) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2001.047 · Cited by 96
Rat α‐Synuclein Interacts with Tat Binding Protein 1, a Component of the 26S Proteasomal Complex
Ghee, M., Fournier, A., & Mallet, J. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752221.x · Cited by 96
Dopamine quinones interact with α-synuclein to form unstructured adducts
Bisaglia, M., Tosatto, L., Munari, F., Tessari, I., de Laureto, P. P., Mammi, S., & Bubacco, L. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.044 · Cited by 95
Protein–protein interactions of alpha-synuclein in brain homogenates and transfected cells
Payton, J. E., Perrin, R. J., Clayton, D. F., & George, J. M. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00257-1 · Cited by 95
The structure of dopamine induced α-synuclein oligomers
Rekas, A., Knott, R. B., Sokolova, A. V., Barnham, K. J., Perez, K. A., Masters, C. L., Drew, S. C., Cappai, R., Curtain, C. C., & Pham, C. L. L. (2010) · European Biophysics Journal · doi:10.1007/s00249-010-0595-x · Cited by 95
Pathogenic effects of α-synuclein aggregation
Lundvig, D. M. S., Lindersson, E., & Jensen, P. H. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.001 · Cited by 94
Dudek, S. M., & Johnson, G. V. W. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03636.x · Cited by 94
Braga, C. A. C. A., Follmer, C., Palhano, F. L., Khattar, E., de Freitas, M. S., Romão, L. F., Giovanni, S. D., Lashuel, H. A., Silva, J. L., & Foguel, D. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.10.027 · Cited by 94
A regulatable switch mediates self-association in an immunoglobulin fold
Calabrese, M. F., Eakin, C. M., Wang, J., & Miranker, A. D. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1483 · Cited by 92
Book Review: Iron and Parkinson’s Disease
Wolozin, B. L., & Golts, N. (2002) · The Neuroscientist · doi:10.1177/107385840200800107 · Cited by 90
α-Synuclein Can Function as an Antioxidant Preventing Oxidation of Unsaturated Lipid in Vesicles
Zhu, M., Qin, Z., Hu, D., Munishkina, L. A., & Fink, A. L. (2006) · Biochemistry · doi:10.1021/bi052584t · Cited by 89
Exploring the Structural Details of Cu(I) Binding to α-Synuclein by NMR Spectroscopy
Binolfi, A., Valiente‐Gabioud, A. A., Durán, R., Zweckstetter, M., Griesinger, C., & Fernández, C. O. (2010) · Journal of the American Chemical Society · doi:10.1021/ja107842f · Cited by 86
Ono, K., Ikemoto, M., Kawarabayashi, T., Ikeda, M., Nishinakagawa, T., Hosokawa, M., Shoji, M., Takahashi, M., & Nakashima, M. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.03.002 · Cited by 85
Ådén, E., Carlsson, M., Poortvliet, E., Stenlund, H. C., Linder, J., Edström, M., Forsgren, L., & Håglin, L. (2011) · Nutritional Neuroscience · doi:10.1179/174313211x12966635733312 · Cited by 85
Ryo, A., Togo, T., Nakai, T., Hirai, A., Nishi, M., Yamaguchi, A., Suzuki, K., Hirayasu, Y., Kobayashi, H., Perrem, K., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507026200 · Cited by 85
Oyanagi, K., Kawakami, E., Kikuchi‐Horie, K., Ohara, K., Ogata, K., Takahama, S., Wada, M., Kihira, T., & YASUI, M. (2006) · Neuropathology · doi:10.1111/j.1440-1789.2006.00672.x · Cited by 85
Hinault, M., Cuendet, A. F. H., Mattoo, R. U. H., Mensi, M., Dietler, G., Lashuel, H. A., & Goloubinoff, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127753 · Cited by 84
19F NMR Studies of α-Synuclein Conformation and Fibrillation
Li, C., Lutz, E. A., Slade, K. M., Ruf, R. A. S., Wang, G.-F., & Pielak, G. J. (2009) · Biochemistry · doi:10.1021/bi900872p · Cited by 84
α‐Synuclein–synaptosomal membrane interactions
Jo, E., Darabie, A. A., Han, K. A., Tandon, A., Fraser, P. E., & McLaurin, J. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04250.x · Cited by 83
Effect of Dehydration on the Aggregation Kinetics of Two Amyloid Peptides
Mukherjee, S., Chowdhury, P. K., & Gai, F. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp809817s · Cited by 83
Metal changes in CSF and peripheral compartments of parkinsonian patients
Bocca, B., Alimonti, A., Senofonte, O., Pino, A., Violante, N., Petrucci, F., Sancesario, G., & Forte, G. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.007 · Cited by 82
Eichner, T., & Radford, S. E. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.01.013 · Cited by 81
Role of Advanced Glycation on Aggregation and DNA Binding Properties of α-Synuclein
Padmaraju, V., Bhaskar, J. J., Rao, U. J. S. P., Salimath, P. V., & Rao, K. S. J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101965 · Cited by 80
Hashimoto, T., Nishi, K., Nagasao, J., Tsuji, S., & Oyanagi, K. (2008) · Brain Research · doi:10.1016/j.brainres.2007.12.033 · Cited by 79
Annular α‐synuclein species from purified multiple system atrophy inclusions
Pountney, D. L., Lowe, R. D., Quilty, M. C., Vickers, J. C., Voelcker, N. H., & Gai, W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02533.x · Cited by 77
Engel, R., Westphal, A. H., Huberts, D. H. E. W., Nabuurs, S. M., Lindhoud, S., Visser, A. J. W. G., & van Mierlo, C. P. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802393200 · Cited by 76
Meuvis, J., Gérard, M., Desender, L., Baekelandt, V., & Engelborghs, Y. (2010) · Biochemistry · doi:10.1021/bi1010927 · Cited by 74
The Synucleins Are a Family of Redox-Active Copper Binding Proteins
Davies, P., Wang, X., Sarell, C. J., Drewett, A., Marken, F., Viles, J. H., & Brown, D. R. (2010) · Biochemistry · doi:10.1021/bi101582p · Cited by 73
Agrin binds α-synuclein and modulates α-synuclein fibrillation
Liu, I., Uversky, V. N., Munishkina, L. A., Fink, A. L., Halfter, W. M., & Cole, G. J. (2005) · Glycobiology · doi:10.1093/glycob/cwj014 · Cited by 72
Self-citationKaul, S., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. G. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.05.022 · Cited by 72
Redox activity of α-synuclein–Cu is silenced by Zn7-metallothionein-3
Meloni, G., & Vašák, M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.02.003 · Cited by 72
Calcium-Triggered Membrane Interaction of the α-Synuclein Acidic Tail
Tamamizu‐Kato, S., Kosaraju, M. G., Kato, H., Raussens, V., Ruysschaert, J., & Narayanaswami, V. (2006) · Biochemistry · doi:10.1021/bi060939i · Cited by 72
DJ‐1 is present in a large molecular complex in human brain tissue and interacts with α‐synuclein
Meulener, M. C., Graves, C. L., Sampathu, D. M., Armstrong‐Gold, C. E., Bonini, N. M., & Giasson, B. I. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03145.x · Cited by 71
Interaction of α‐synuclein and synphilin‐1: effect of Parkinson's disease‐associated mutations
Kawamata, H., McLean, P. J., Sharma, N., & Hyman, B. T. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00301.x · Cited by 71
Cho, M., Kim, H., Bernadó, P., Fernández, C. O., Blackledge, M. J., & Zweckstetter, M. (2007) · Journal of the American Chemical Society · doi:10.1021/ja067482k · Cited by 71
Microtubule depolymerization potentiates alpha-synuclein oligomerization
Esteves, A. R. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/neuro.24.005.2009 · Cited by 71
Crowding Alone Cannot Account for Cosolute Effect on Amyloid Aggregation
Sukenik, S., Politi, R., Ziserman, L., Danino, D., Friedler, A., & Harries, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015608 · Cited by 70
Oligomeric alpha‐synuclein and its role in neuronal death
Brown, D. R. (2010) · IUBMB Life · doi:10.1002/iub.316 · Cited by 70
Annular alpha-synuclein oligomers are potentially toxic agents in alpha-synucleinopathy. Hypothesis
Pountney, D. L., Voelcker, N. H., & Gai, W. (2005) · Neurotoxicity Research · doi:10.1007/bf03033776 · Cited by 69
Human Polycomb protein 2 promotes α-synuclein aggregate formation through covalent SUMOylation
Oh, Y., Kim, Y. M., Mouradian, M. M., & Chung, K. C. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.039 · Cited by 68
Intrinsically disordered proteins may escape unwanted interactions via functional misfolding
Uversky, V. N. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.03.010 · Cited by 68
Self-citationGérard, M., Debyser, Z., Desender, L., Kahle, P. J., Baert, J. H., Baekelandt, V., & Engelborghs, Y. (2006) · The FASEB Journal · doi:10.1096/fj.05-5126fje · Cited by 66
α‐Synuclein exhibits competitive interaction between calmodulin and synthetic membranes
Lee, D., Lee, S., Lee, E., Chang, C., & Paik, S. R. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01024.x · Cited by 66
Lee, F. K. M., Wong, A. K. Y., Lee, Y. W., Wan, O. W., Chan, H. Y. E., & Chung, K. K. K. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06124.x · Cited by 65
Bhak, G., Lee, J., Hahn, J., & Paik, S. R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004177 · Cited by 62
Metal binding to alpha-synuclein peptides and its contribution to toxicity
Brown, D. R. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.103 · Cited by 61
Tissue transglutaminase modulates α‐synuclein oligomerization
Segers‐Nolten, I. M. J., Wilhelmus, M. M. M., Veldhuis, G., et al. (2008) · Protein Science · doi:10.1110/ps.036103.108 · Cited by 60
Peneder, T. M., Scholze, P., Berger, M. L., Reither, H., Heinze, G., Bertl, J., Bauer, J., Richfield, E. K., Hornykiewicz, O., & Pifl, C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.017 · Cited by 59
Characterization of the Non-Fibrillar α-Synuclein Oligomers
Hong, D.-P., Han, S., Fink, A. L., & Uversky, V. N. (2011) · Protein and Peptide Letters · doi:10.2174/092986611794578332 · Cited by 58
Self-citationRecombinant EWS-FLI1 Oncoprotein Activates Transcription
Üren, A., Tcherkasskaya, O., & Toretsky, J. A. (2004) · Biochemistry · doi:10.1021/bi048776q · Cited by 57
α-Synuclein Tertiary Contact Dynamics
Lee, J. C., Lai, B. T., Kozak, J. J., Gray, H. B., & Winkler, J. R. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp068604y · Cited by 57
αB-Crystallin is a major component of glial cytoplasmic inclusions in multiple system atrophy
Pountney, D. L., Treweek, T. M., Chataway, T., Huang, Y. M., Chegini, F., Blumbergs, P. C., Raftery, M. J., & Gai, W. P. (2005) · Neurotoxicity Research · doi:10.1007/bf03033778 · Cited by 56
Ladiwala, A. R. A., Mora‐Pale, M., Lin, J. C., Bale, S. S., Fishman, Z. S., Dordick, J. S., & Tessier, P. M. (2011) · ChemBioChem · doi:10.1002/cbic.201100123 · Cited by 54
Cited by
Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?
Reeve, A., Simcox, E., & Turnbull, D. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.01.004 · Cited by 947
Bendor, J. T., Logan, T. P., & Edwards, R. H. (2013) · Neuron · doi:10.1016/j.neuron.2013.09.004 · Cited by 825
α‐Synuclein aggregation nucleates through liquid‐liquid phase separation
Ray, S., Singh, N., Kumar, R., Patel, K., Pandey, S., Datta, D., Mahato, J., Panigrahi, R., Navalkar, A., Mehra, S., et al. (2020) · Nature Chemistry · doi:10.1038/s41557-020-0465-9 · Cited by 863
Parkinson's disease: Mechanisms, translational models and management strategies
Raza, C., Anjum, R., & Shakeel, N. U. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.057 · Cited by 603
Lee, W.-H., Loo, C.-Y., Bebawy, M., Luk, F., Mason, R., & Rohanizadeh, R. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311040002 · Cited by 537
Metadata
- Authors
- Breydo, L., Wu, J. W., & Uversky, V. N.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 1822
- Issue
- 2
- Pages
- 261-285
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W1977682751
- Cited by
- 657
- References
- 438
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.